Literature DB >> 2469766

Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties.

R G Andrews1, J W Singer, I D Bernstein.   

Abstract

We determined whether human marrow cells that directly form colonies in vitro could be distinguished from cells that generate or become CFC only after LTMC in the presence of irradiated marrow stromal cells. In previous studies, an anti-CD33 antibody, L4F3, and complement (C') were used to lyse nearly all CFC in marrow, and the remaining cells generated CFC in LTMC. In the present studies, marrow cells were treated with L4F3 + C' and the remaining CD33- cells were separated into CD34+ and CD34- populations and placed in LTMC. Only the CD34+ cells were found to generate significant numbers of CFC. To compare the CD33-CD34+ and CD33+CD34+ cells, we isolated each cell population using two-color FACS. Only LTMCs of the CD33-CD34+ cells generated CFC for greater than 5 wk. In contrast, cells that expressed both the CD33 and CD34 antigens, which contained most of the CFC, generated few CFC in LTMC. Fractionation of marrow cells based on right angle and forward light scattering suggested that precursors for CFC have low right angle and low forward light scattering properties. The CD33-CD34+ marrow cells were therefore further fractionated based on light scatter characteristics. Cells with low right angle and low forward light scatter formed few or no colonies on direct culture, yet generated greater numbers of CFC after 4 wk of LTMC than did cells with low right angle and high forward light scatter. Most (87-98%) CFC generated in the LTMCs that were initiated with CD33-CD34+ cells were found to express the CD33 antigen. Thus, hematopoietic progenitors with differing proliferative and differentiative potentials can be directly separated on the basis of their expression of CD33 and CD34 cell surface antigens and their light scatter properties.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2469766      PMCID: PMC2189320          DOI: 10.1084/jem.169.5.1721

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

2.  Antigenic analysis of hematopoiesis. IV. The My-11 hematopoietic cell surface antigen is expressed by myelomonocytic and lymphoid, but not erythroid, progenitor cells.

Authors:  L C Strauss; C Brovall; M J Fackler; J F Schwartz; J H Shaper; M R Loken; C I Civin
Journal:  Exp Hematol       Date:  1986-11       Impact factor: 3.084

3.  Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors.

Authors:  R G Andrews; J W Singer; I D Bernstein
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

4.  Antigen CD34+ marrow cells engraft lethally irradiated baboons.

Authors:  R J Berenson; R G Andrews; W I Bensinger; D Kalamasz; G Knitter; C D Buckner; I D Bernstein
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Anti-HEL cell monoclonal antibodies recognize determinants that are also present in hemopoietic progenitors.

Authors:  T Papayannopoulou; M Brice; T Yokochi; P S Rabinovitch; D Lindsley; G Stamatoyannopoulos
Journal:  Blood       Date:  1984-02       Impact factor: 22.113

6.  Surface antigenic determinants on human pluripotent and unipotent hematopoietic progenitor cells.

Authors:  M P Bodger; C A Izaguirre; H A Blacklock; A V Hoffbrand
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

7.  Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice.

Authors:  J E Dick; M C Magli; D Huszar; R A Phillips; A Bernstein
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

8.  Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development.

Authors:  M R Loken; V O Shah; K L Dattilio; C I Civin
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

9.  A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells.

Authors:  J D Griffin; D Linch; K Sabbath; P Larcom; S F Schlossman
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

10.  Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors.

Authors:  J P McKearn; J McCubrey; B Fagg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

View more
  54 in total

Review 1.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

2.  Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.

Authors:  Vera S Donnenberg; Albert D Donnenberg; Ludovic Zimmerlin; Rodney J Landreneau; Rohit Bhargava; Ryan A Wetzel; Per Basse; Adam M Brufsky
Journal:  Cytometry B Clin Cytom       Date:  2010-04-30       Impact factor: 3.058

Review 3.  Acute myeloid leukemia stem cells and CD33-targeted immunotherapy.

Authors:  Roland B Walter; Frederick R Appelbaum; Elihu H Estey; Irwin D Bernstein
Journal:  Blood       Date:  2012-01-27       Impact factor: 22.113

4.  Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors.

Authors:  N M Sposi; L I Zon; A Carè; M Valtieri; U Testa; M Gabbianelli; G Mariani; L Bottero; C Mather; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 5.  The stem cell continuum: considerations on the heterogeneity and plasticity of marrow stem cells.

Authors:  Peter J Quesenberry; G Dooner; M Dooner; G Colvin
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 6.  Specific protein markers for stem cell cross-talk with neighboring cells in the environment.

Authors:  Kyung Soo Park; Seung Won Shin; Jeong-Woo Choi; Soong Ho Um
Journal:  Int J Stem Cells       Date:  2013-11       Impact factor: 2.500

7.  A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia.

Authors:  Sayed Shahabuddin Hoseini; Hongfen Guo; Zhihao Wu; Miho Nakajima Hatano; Nai-Kong V Cheung
Journal:  Blood Adv       Date:  2018-06-12

Review 8.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

9.  Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells.

Authors:  G Hahn; R Jores; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 10.  Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors.

Authors:  G S Chatta; D C Dale
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.